Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc. (IMPL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IMPL · as of Dec 31, 2023
Ownership Breakdown
2
Institutional Holders
▼ 29 vs Q3
$341,019
Total Inst. Value
▼ $7.01M vs Q3
23.90M
Shares Outstanding
freeFloat 33.45%
2.76M
13F Shares Held
▼ 14.33M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IMPL largest shareholders · institutional ownership
Q4 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VENBIO PARTNERS LLC pharmaceutical preparations | 2.76M | 11.62% | 11.62% | $340.83M | Feb 14, 2024 | — held |
ST GERMAIN D J CO INC pharmaceutical preparations | 1.5K | 0.63% | 0.63% | $185,000 | Jan 2, 2024 | — held |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Mar 11, 2024 | EXIT |
RAYMOND JAMES & ASSOCIATES pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Jan 16, 2024 | EXIT |
MORGAN STANLEY pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Aug 16, 2024 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2024 | EXIT |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2024 | EXIT |
LASRY MARC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 9, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2023 vs prior quarter
Q4 2023
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares29
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-29
0 new / 29 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IMPL insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
6
Sell transactions
0.50
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Vivo Capital VIII, LLC 10 percent owner | Dec 15, 2023 | Sale | 87,934 | $0.29 | $25.5K | 2.45M | Form 4 ↗ |
Vivo Capital VIII, LLC 10 percent owner | Dec 18, 2023 | Sale | 209,029 | $0.11 | $23.0K | 2.24M | Form 4 ↗ |
Vivo Capital VIII, LLC 10 percent owner | Dec 19, 2023 | Sale | 208,657 | $0.08 | $16.7K | 2.03M | Form 4 ↗ |
Vivo Capital VIII, LLC 10 percent owner | Dec 15, 2023 | Sale | 12,066 | $0.29 | $3.5K | 337.6K | Form 4 ↗ |
Vivo Capital VIII, LLC 10 percent owner | Dec 18, 2023 | Sale | 28,682 | $0.11 | $3.2K | 308.9K | Form 4 ↗ |
Vivo Capital VIII, LLC 10 percent owner | Dec 19, 2023 | Sale | 28,632 | $0.08 | $2.3K | 280.3K | Form 4 ↗ |
BROOKFIELD Corp /ON/ 10 percent owner | Nov 30, 2023 | J-Other | 445,294 | $0.01 | $4.5K | 3.12M | Form 4 ↗ |
Oaktree GCP Fund Delaware Holdings, L.P. 10 percent owner | Nov 30, 2023 | J-Other | 445,294 | $0.01 | $4.5K | 3.12M | Form 4 ↗ |
Oaktree-TCDRS Strategic Credit, LLC 10 percent owner | Nov 30, 2023 | J-Other | 445,294 | $0.01 | $4.5K | 3.12M | Form 4 ↗ |
Cline Darren S director | Jun 16, 2023 | Award | 13,222 | $1.34 | $17.7K | 13.2K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Impel Pharmaceuticals Inc. (IMPL) is primarily owned by institutional investors, who hold approximately 11.6% of total shares outstanding. Company insiders own approximately 66.55%, while retail and public investors account for the remaining 21.90%.
The largest institutional shareholder of Impel Pharmaceuticals Inc. is VENBIO PARTNERS LLC, holding approximately 2.76 million shares — equal to 11.62% of outstanding shares — as of December 31, 2023.
A total of 2 institutional investors currently hold IMPL stock, with a combined institutional value of approximately $341,019 as of the most recent 13F filing period.
Frequently asked questions
IMPL ownershipImpel Pharmaceuticals Inc. (IMPL) is primarily owned by institutional investors, who hold approximately 11.6% of shares. The largest shareholder is VENBIO PARTNERS LLC with a 11.62% stake. Company insiders hold 66.55%. Data sourced from SEC Form 13F as of December 31, 2023.